Commitment to partnership research

The Carnot institutes network combines scientific excellence with professionalism and is committed to develop research for companies’ innovation.


  • 18% of the French public laboratory workforces
  • 50% of the R&D funded by companies in French public research

Data Moove enhances the tourist experience with improved sources of information using flow aggregation

Such products have been jointly developed under a strategic research partnership with Carnot Télécom & Société numérique (EURECOM).

Partnership Télécom & Société numérique Carnot Institute - Data Moove

While the dental implant market is bursting, Anthogyr, in co-operation with Ingénierie@Lyon, innovates to improve efficiency

With a better control of the behaviour of new zirconia-based composite features Anthogyr has been able to improve the stability of its ceramics and unlock innovation potential to gain a relevant position at an international level.

Partnership Ingénierie @ Lyon Carnot Institute and Anthogyr

Carnot ICÉEL contributes to Crossject successful completion of a specific needle-less syringe

Crossject has reached its intended goal of providing safe medical injection without the use of a needle in a format adapted to the needs of both the professionals and the patients.

Partnership with ICÉEL Carnot Institute & Crossject

R&D partnership for innovation


Leti Innovation Days 2018 on July 4-5th will include a series of keynotes and panel sessions from industry leaders and academics. Along the conference, a special exhibition will be open in the afternoons, and will gather microelectronics industrials and successful start-ups. 

This year, there will be 7 satellite workshops on various technical fields :

  • Design for 3D
  • Lithography
  • Quantum
  • Silicon photonics
  • Memory
  • 5 G
  • MEMS & sensors 

More information




Curie Cancer Carnot Institute and Freenome announce a strategic collaboration to evaluate Freenome’s artificial intelligence (AI) genomics platform as a novel tool to predict patient response to immuno-oncology therapies by observing changes in circulating cell-free biomarkers.

At the end of December 2017, a framework contract was signed between CALYM and the Institut Roche to define the terms of a joint call for projects for the development of preclinical and translational research partnerships in onco-hematology.